Stocks diverge as all eyes on corporate earnings

Weather - Sydney 10°C

Stocks diverge as all eyes on corporate earnings

ECONOMY 12.02.2026

Stocks diverge as all eyes on corporate earnings / Photo: © AFP/File

Stock markets diverged Thursday as traders digested a string of company earnings that mostly suggested economic resilience in line with a bumper US jobs report for January, even though the chances of Federal Reserve interest rate cuts receded.

Change text size:

While Wall Street opened higher its main indices slid into the red during morning trading, with investors looking forward to Friday's release of consumer price inflation (CPI) data for January for further clues on potential rate cuts.

"Caught between payrolls and CPI, US markets have found themselves unable to maintain momentum," said Chris Beauchamp, chief market analyst at IG trading platform, referring to the jobs report and inflation data.

In Europe, Paris ended with a gain after striking a fresh record high. London's blue-chip FTSE 100 index did the same but ended the day lower, as data showed the British economy managing only tepid growth in the final quarter of last year.

"The strength seen in Europe... comes from improved earnings data from some of the big hitters," said Joshua Mahony, chief market analyst at Scope Markets.

Shares in German industrial giant Siemens jumped 5.8 percent as it raised its outlook for the year after a strong first quarter boosted by spending on artificial intelligence.

In Paris, RayBan maker EssilorLuxottica shares rose 3.8 percent as its fourth-quarter earnings beat market expectations. Hermes climbed 2.8 percent after reporting 2025 sales growth despite the impact of US tariffs and a weaker dollar.

But French pharma giant Sanofi sank 4.2 percent after the surprise ouster of its chief executive Paul Hudson, suggesting growing concerns about the company's pipeline for new products. He will be replaced by Belen Garijo, currently chief of Germany's Merck KGaA.

Asian markets were subdued after the lacklustre US close on Wednesday, where tech firms came in for further selling amid concerns of the scale of massive AI investments and their eventual impact on various industries.

"US stocks are still failing to offer much in the way of compelling risk-reward, especially as AI fear continues to move from sector to sector," said IG's Beauchamp.

Investors were also reacting to a stronger than expected US jobs report on Wednesday that allayed concerns about the state of the world's biggest economy, even though it reduced expectations for Fed interest rate cuts to spur growth.

Around 130,000 US jobs were created last month, more than double what was forecast, while unemployment unexpectedly dipped.

The reading soothed concerns about the economy that had been stoked by a report earlier this week showing weak US consumer activity.

"This was a solid report across headline job creation, unemployment, and wage growth, easing concerns over the health of the US labour market," said Fiona Cincotta, senior market analyst at City Index.

However, "the markets have pushed back on expectations for the next rate cut by the Federal Reserve to July, compared to June previously," she added.

- Key figures at around 1630 GMT -

New York - Dow: DOWN 1.0 percent at 49,634.57 points

New York - S&P 500: DOWN 1.2 percent at 6,858.31

New York - Nasdaq: DOWN 1.8 percent at 22,649.87

London - FTSE 100: DOWN 0.7 at 10,402.44 (close)

Paris - CAC 40: UP 0.3 percent at 8,340.56 (close)

Frankfurt - DAX: FLAT at 24,852.69 (close)

Tokyo - Nikkei 225: FLAT at 57,639.84 (close)

Hong Kong - Hang Seng Index: DOWN 0.9 percent at 27,032.54 (close)

Shanghai - Composite: UP 0.1 percent at 4,134.02 (close)

Euro/dollar: DOWN at $1.1867 from $1.1874 on Wednesday

Pound/dollar: DOWN at $1.3624 from $1.3628

Dollar/yen: DOWN at 152.46 yen from 153.14 yen

Euro/pound: DOWN at 87.10 pence from 87.13 pence

Brent North Sea Crude: DOWN 1.7 percent at $68.19 per barrel

West Texas Intermediate: DOWN 1.8 percent at $63.48 per barrel

burs-rl/jj

V.Bennett--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size:

The National Times - Stocks diverge as all eyes on corporate earnings